PATENT CLAIM ANALYSIS

Application Number: 16009308
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "161000"]

Abstract:
Disclosed is a compound of Formula 1, and a pharmaceutically acceptable salt thereof. This disclosure also relates to materials and methods for preparing the compound of Formula 1, to pharmaceutical compositions which contain it, and to its use for treating diseases, disorders, and conditions associated with GPR6.

Claim (Index 12):
The method according to  claim 10 , wherein the compound or pharmaceutically acceptable salt is administered at a dose within a range selected from the group consisting of about 30 mg/kg to about 40 mg/kg, about 35 mg/kg to about 45 mg/kg, about 40 mg/kg to about 50 mg/kg, about 45 mg/kg to about 55 mg/kg, about 50 mg/kg to about 60 mg/kg, about 55 mg/kg to about 65 mg/kg, and about 60 mg/kg to about 70 mg/kg.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.42105
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15979069', '15118461', '15621761', '15334198', '14577480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7982363171760357
- 35 USC 102 Novelty (BERT): 0.5063381987174639
- Combined Prediction Score: 0.7690465053301786
- Mean Citation Score: 210.882644
- Max Citation Score: 219.74248
- Similarity Product: 129.9654402361345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test